MedPath

flawless photo finish

Approved
Approval ID

35bb0ac4-6abd-ca75-e063-6394a90a26cd

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 22, 2025

Manufacturers
FDA

NEXTEX CORPORATION

DUNS: 006596095

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Zinc Oxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code85575-208
Application NumberM020
Product Classification
M
Marketing Category
C200263
G
Generic Name
Zinc Oxide
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 22, 2025
FDA Product Classification

INGREDIENTS (18)

CAPRYLIC/CAPRIC TRIGLYCERIDEInactive
Code: C9H2L21V7U
Classification: IACT
CERAMIDE 3Inactive
Code: 4370DF050B
Classification: IACT
CYCLOHEXASILOXANEInactive
Code: XHK3U310BA
Classification: IACT
CYCLOPENTASILOXANEInactive
Code: 0THT5PCI0R
Classification: IACT
DIMETHICONEInactive
Code: 92RU3N3Y1O
Classification: IACT
DIMETHICONE CROSSPOLYMERInactive
Code: UF7620L1W6
Classification: IACT
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)Inactive
Code: 9E4CO0W6C5
Classification: IACT
DIMETHICONOL (2000 CST)Inactive
Code: T74O12AN6Y
Classification: IACT
CI 77491Inactive
Code: 1K09F3G675
Classification: IACT
CI 77492Inactive
Code: EX438O2MRT
Classification: IACT
HYDROGEN DIMETHICONE (20 CST)Inactive
Code: 12Z59IF64N
Classification: IACT
POLYHYDROXYSTEARIC ACID (2300 MW)Inactive
Code: YXH47AOU0F
Classification: IACT
PEG-10 DIMETHICONE (600 CST)Inactive
Code: 8PR7V1SVM0
Classification: IACT
TETRAHEXYLDECYL ASCORBATEInactive
Code: 9LBV3F07AZ
Classification: IACT
ZINC OXIDEActive
Quantity: 160 mg in 1 g
Code: SOI2LOH54Z
Classification: ACTIB
CI 77499Inactive
Code: XM0M87F357
Classification: IACT
ALPHA-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMERInactive
Code: 9NH1UDD2RR
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/22/2025

Package Label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 4/22/2025

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 4/22/2025

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 4/22/2025

WARNINGS SECTION

LOINC: 34071-1Updated: 4/22/2025

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 4/22/2025

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 4/22/2025

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 4/22/2025

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 4/22/2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

flawless photo finish - FDA Drug Approval Details